Analysts expect over 2018 rising revenue Amgen

Tomorrow the American Amgen will report its past quarter's results. Over the current book year the total revenue will be 23,17 billion USD (consensus estimates). This is slightly more than 2017's revenue of 22,85 billion USD.

Historical revenues and results Amgen plus estimates 2018

The analysts expect for 2018 a net profit of 9,39 billion USD. For this year most of the analysts expect a profit per share of 14,01 USD. The price/earnings-ratio therefore equals 14,4.

For this year the analysts expect a dividend of 5,22 USD per share. Thus the dividend yield equals 2,59 percent. The average dividend yield of the biotech companies equals a limited 0,5 percent.

Most recent target prices around 208 USD

The most recent recommendations for the biotech company are from Morgan Stanley , JP Morgan and Jefferies & Co..

Amgen 's market capitalization is around 148,97 billion USD. The Amgen stock was the past 12 months quite unstable. Since last October the stock is 13 percent higher. This year the stock price moved between 163 and 210 dollar. Since 2008 the stock price is almost 306 percent higher.

On Friday the stock closed at 201,8 USD.

Historical stock prices Amgen period 2007-2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.